CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy.
Journal Information
Full Title: Exp Hematol Oncol
Abbreviation: Exp Hematol Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declarations Competing interestsThe authors declare no competing interests. Ethic approval and consent to participate. Not applicable. Consent for publicationNot applicable. Competing interests The authors declare no competing interests."
Funding Disclosure
Evidence found in paper:
"Funding This work was supported by the National Natural Science Foundation of China (No. 82273381)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025